Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03867448 · ClinicalTrials.gov registry record

Study of Endocrine-Related Conditions and Physiology

A clinical trial of Endocrine Disease, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT03867448: Recruiting study of Endocrine Disease, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT03867448 is a study of Endocrine Disease that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 1,000 participants, below the 4,529-participant average among 4 other Endocrine Disease trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03867448, a study of Endocrine Disease, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Background: Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the function of other tissues in the body. Researchers want to study people who may have endocrine disorders. They want to learn more about the conditions that affect endocrine glands. Objective: To study adults with a variety of endocrine disorders for research and physician education. Eligibility: Adults ages 18 and older who have an endocrine or metabolic-related disorder Healthy volunteers 18 and older Design: Participants will be screened with a review of their medical records. Participants will have a physical exam and medical history. The length of the study and the schedule will vary by participant. Tests may include: Blood and urine tests Stool and saliva samples Imaging studies: Participants will lie on a table while a machine takes pictures of the body. They may be injected with a substance to make their organs more visible in the pictures. Tests of endocrine tissue function Consultation with other specialists Sleep study Medical photographs Participants may be treated for their endocrine disorder. This could include: Surgery. If tissue is removed during surgery, it may be studied. Radiation Medicine Participants may have genetic testing. This will be done with a small amount of blood, cells from a cheek swab, or saliva. Sponsoring Institution: National Institute of Digestive, Diabetes and Kidney Disease

Primary Outcome

determination of diagnosis and/or treatment of an endocrine disorder

Conditions Studied

Endocrine Disease

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2019-03-27
Est. Completion 2036-01-01
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

490 total trials

What NCT03867448 shows while recruiting

NCT03867448 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 4,529-participant average among 4 other Endocrine Disease trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Endocrine Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03867448 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03867448 about?

NCT03867448 is a clinical study titled "Study of Endocrine-Related Conditions and Physiology". Background: Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the function of other tissues in the body. Researchers want to study people who may have endocrine disorders. They want to learn more about the co...

What is the current status of trial NCT03867448?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-03-27. Estimated completion is 2036-01-01.

What conditions does trial NCT03867448 study?

This clinical trial studies the following conditions: Endocrine Disease.

Who is sponsoring clinical trial NCT03867448?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03867448 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endocrine Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT03867448

Source: ClinicalTrials.gov NCT03867448, the US trial registry maintained by the National Library of Medicine. NCT03867448 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.